Lv5
1210 积分 2023-05-24 加入
Clinical Outcomes of 3 Versus 4 Fractions of Magnetic Resonance Image-Guided Brachytherapy in Cervical Cancer
29天前
已完结
Pattern of pelvic recurrence in MRI-only adaptive brachytherapy for locally advanced cervical cancer
1个月前
已完结
Image guided cervical brachytherapy practice patterns: 2023/2024 survey of the American brachytherapy society
1个月前
已完结
PIK3CA and ARID1A mutations in recurrent/metastatic cervical cancer: The NRG Oncology/Gynecologic Oncology Group-0240 National Institutes of Health Beau Biden Cancer Moonshot (LBA 2)
1个月前
已完结
Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial
1个月前
已完结
Sacituzumab tirumotecan (SKB264/MK-2870) in patients (pts) with previously treated locally recurrent or metastatic triple-negative breast cancer (TNBC): Results from the phase III OptiTROP-Breast01 study
1个月前
已完结
Sacituzumab govitecan for Chinese patients with recurrent/metastatic cervical cancer: Interim analysis of the phase II basket study EVER-132-003
1个月前
已完结
Antibody–drug conjugates come of age in oncology
1个月前
已完结
Tissue Factor: A Conventional or Alternative Target in Cancer Therapy
1个月前
已关闭
Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study
1个月前
已完结
皖公网安备34019202002308
